CardiaTouch is an emerging medical device co. that develops haptic technologies aimed to reduce operative risk and improve outcome of cardiac procedures by using sense of touch. Two patents and two patent applications with notices of allowance have been issued. CardiaTouch was awarded a grant from SUNY Research Foundation that enabled proof of concept in Stony Brook’s Bioengineering lab and an IRB approved protocol for in human data collection.